BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 8826559)

  • 1. Risperidone-induced neuroleptic malignant syndrome.
    Sharma R; Trappler B; Ng YK; Leeman CP
    Ann Pharmacother; 1996; 30(7-8):775-8. PubMed ID: 8826559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic malignant syndrome during a change from haloperidol to risperidone.
    Reeves RR; Mack JE; Torres RA
    Ann Pharmacother; 2001 Jun; 35(6):698-701. PubMed ID: 11408988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone-induced neuroleptic malignant syndrome: a case report and review.
    Meterissian GB
    Can J Psychiatry; 1996 Feb; 41(1):52-4. PubMed ID: 8919425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
    Khouri C; Planès S; Logerot S; Villier C; Mallaret M
    Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotics leading to neuroleptic malignant syndrome in pregnancy.
    Ghaffari N; Dossett E; Lee RH; Aghajanian P
    Obstet Gynecol; 2012 Feb; 119(2 Pt 2):436-438. PubMed ID: 22270430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case study. Risperidone-Induced neuroleptic malignant syndrome in an adolescent.
    Robb AS; Chang W; Lee HK; Cook MS
    J Child Adolesc Psychopharmacol; 2000; 10(4):327-30. PubMed ID: 11191694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical neuroleptic malignant syndrome - A case report.
    Vellekkatt F; Kuppili PP; Bharadwaj B; Menon V
    Asian J Psychiatr; 2019 Jun; 43():7-8. PubMed ID: 31071486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool.
    Sokoro AA; Zivot J; Ariano RE
    Ann Pharmacother; 2011 Sep; 45(9):e50. PubMed ID: 21878660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome and atypical antipsychotic drugs.
    Ananth J; Parameswaran S; Gunatilake S; Burgoyne K; Sidhom T
    J Clin Psychiatry; 2004 Apr; 65(4):464-70. PubMed ID: 15119907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome with risperidone.
    Gleason PP; Conigliaro RL
    Pharmacotherapy; 1997; 17(3):617-21. PubMed ID: 9165568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study of neuroleptic malignant syndrome in the presenium and senium].
    Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
    Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia.
    Aboraya A; Schumacher J; Abdalla E; LePage J; McGhee M; Butcher D; Griffin H; Shahda M
    W V Med J; 2002; 98(2):63-5. PubMed ID: 12048741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone-induced neuroleptic malignant syndrome.
    Bajjoka I; Patel T; O'Sullivan T
    Ann Emerg Med; 1997 Nov; 30(5):698-700. PubMed ID: 9360586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuroleptic malignant syndrome caused by olanzapine, risperidone and haloperidol].
    Marloth PV; Ladefoged MR; Boesen MS
    Ugeskr Laeger; 2022 Nov; 184(45):. PubMed ID: 36345898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
    Liu PY; Wu PC; Chen CY; Chen YC
    Gen Hosp Psychiatry; 2011; 33(1):84.e5-7. PubMed ID: 21353143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fever, confusion, acute kidney injury: is this atypical neuroleptic malignant syndrome following polypharmacy with clozapine and risperidone?
    Cherry S; Siskind D; Spivak V; Wysoczanski D; Halangoda P
    Australas Psychiatry; 2016 Dec; 24(6):602-603. PubMed ID: 27194777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical neuroleptic malignant syndrome associated with risperidone treatment in two adolescents.
    Zalsman G; Lewis R; Konas S; Loebstein O; Goldberg P; Burguillo F; Nahshoni E; Munitz H
    Int J Adolesc Med Health; 2004; 16(2):179-82. PubMed ID: 15266995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies.
    Sechi G; Agnetti V; Masuri R; Deiana GA; Pugliatti M; Paulus KS; Rosati G
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Aug; 24(6):1043-51. PubMed ID: 11041543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic malignant syndrome due to olanzapine.
    Hall KL; Taylor WH; Ware MR
    Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.